6 completed, 1 unknown. 3 Phase 2, 3 Phase 3, 1 Not applicable, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 3 | 3 | Completed 3 |
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Fatty Acids, Essential: new trials by email Literature Review of Fatty Acids, Essential trials Research Report on Fatty Acids, Essential
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Randomized Controlled Trial in South Africa Comparing the Efficacy of Complementary Food Products on Child Growth Fortified fat-based paste with essential fatty acids, DHA, ARA, phytase, L-lysine, potassium, phosphorous, magnesium and manganese, Fortified fat-based paste with essential fatty acids - Malnutrition | Not applicable | Completed | North-West University, South Africa | 750 | 2013-09-01 | 2017-11-30 |
| Omega-3 Fatty Acids and Insulin Sensitivity Omega-3, placebo - Insulin Resistance | Phase 3 | Completed | Mayo Clinic | 31 | 2012-12-21 | 2017-03-03 |
| Essential Fatty Acids in Adult ADHD Essential fatty acids - Adult Attention Deficit Hyperactivity Disorder | Phase 3 | Completed | Universität des Saarlandes | 100 | 2012-12-01 | 2020-10-29 |
| Nutritional and Dietary Treatment Study for Children/Adults With Autism Nutritional and Dietary Interventions - Autism | Phase 2 | Completed | Arizona State University | 120 | 2011-11-01 | 2014-02-11 |
| Omega-3 Fatty Acids Efficacy in First-episode of Schizophrenia essential fatty acids, olive oil - Schizophrenia | Phase 4 | Unknown | Medical University of Lodz | 80 | 2011-09-01 | 2015-02-18 |
| Study on the Possible Effects of Diet Supplementation With Essential Fatty Acids in Chocolate Craving Volunteers Flaxseed oil, Paraffin + # 2 dye - Addictive Behavior, Abstinence Syndrome | Phase 2 / Phase 3 | Completed | Federal University of São Paulo | 30 | 2010-08-01 | 2011-07-12 |
| Natural Antioxidants in the Treatment of Multiple Sclerosis Ginkgo biloba, Alpha-lipoic acid, Vitamin E/Selenium - Multiple Sclerosis | Phase 1 / Phase 2 | Completed | National Center for Complementary and Integrative Health (NCCIH) | 1999-09-01 | 2006-08-18 |
Attention Deficit Disorder with Hyperactivity (1) · Autistic Disorder (1) · Behavior, Addictive (1) · Compulsive Behavior (1) · Insulin Resistance (1) · Malnutrition (1) · Multiple Sclerosis (1) · Psychotic Disorders (1) · Schizophrenia (1)
Arizona State University (1) · Federal University of São Paulo (1) · Mayo Clinic (1) · Medical University of Lodz (1) · National Center for Complementary and Integrative Health (NCCIH) (1) · North-West University, South Africa (1) · Universität des Saarlandes (1)
United States (3) · Brazil (1) · Germany (1) · Poland (1) · South Africa (1)
Cornelius M Smuts, PhD (1) · Dr. Dennis Bourdette (1) · Ian Lanza, PhD (1) · James B. Adams, PhD (1) · Pedro L Prior, Student (1)
PMID 25852206, PMID 25934131, PMID 28424185, PMID 30649163
5UL1TR000135 (1), KL2TR000136 (1), P50AT000066 (1), T32DK007352 (1), U24DK100469 (1)